QIAGEN lowers 2026 outlook as QuantiFERON immigration testing drops

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. LBRX
2. MRK
3. TRAX
4. LMT
5. FATE
6. KTOS
7. FFAI
8. IRIX
9. BRO
10. AON

Go back to QIAGEN lowers 2026 outlook as QuantiFERON immigration testing drops

QIAGEN reports preliminary Q1 2026 results: achieves adjusted EPS outlook with mixed sales trends; updates full-year 2026 outlook

April 27, 2026 4:16 PM EDT

Sample technologies, QIAcuity and QDI deliver solid growth; QuantiFERON sales affected by significantly lower immigration testing demand

VENLO, the Netherlands--(BUSINESS WIRE)-- QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced preliminary results for the first quarter of 2026, continuing to deliver strong profitability as adjusted diluted earnings per share (EPS) achieved the outlook. Sales trends were mixed, as lower QuantiFERON sales and cautious U.S. Life Sciences customer demand offset solid growth in other areas of the portfolio.

For Q1 2026, preliminary net sales were... More